All In MedTech

FDA Clearance Tracker · P210027-S001

QDOT MICRO™ System, nGEN™ Generator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 24, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P210027-S001
Device name
QDOT MICRO™ System, nGEN™ Generator
Applicant location
Irvine, CA
Received
Nov 29, 2022
Decided
Feb 24, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P210027

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

Approval for software and hardware modifications to the nGEN Generator.

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.